Works matching IS 13889842 AND DT 2020 AND VI 22 AND IP 11

Results: 34

Corrigendum to 'Departments involved during the first episode of acute heart failure and analysis of emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort' [Eur J Heart Fail 2019;21:1231-1244].

Published in:: 2020
Publication type:: corrected article

Figures of the Heart Failure Association: Prof. Lars H. Lund, Chair of the HFA Committee on Registries, Surveys and Epidemiology and HFA Board Member (from 2016).

Published in:

2020

By:

Coats, Andrew J.S.

Publication type:

Biography

Effects of hyperkalaemia and non-adherence to renin-angiotensin-aldosterone system inhibitor therapy in patients with heart failure in Italy: a propensity-matched study.

Published in:

2020

By:

Volterrani, Maurizio;
Perrone, Valentina;
Sangiorgi, Diego;
Giacomini, Elisa;
Iellamo, Ferdinando;
Degli Esposti, Luca;
on the behalf of a LHUs Study Group (see Appendix)

Publication type:

journal article

Myocardial iron content in non‐ischaemic cardiomyopathy: how much is known?

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2047, doi. 10.1002/ejhf.2023

By:

Jankowska, Ewa A.;
Tkaczyszyn, Michał;
Ponikowski, Piotr

Publication type:

Article

Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology

Published in:

2020

By:

Pudil, Radek;
Mueller, Christian;
Čelutkienė, Jelena;
Henriksen, Peter A.;
Lenihan, Dan;
Dent, Susan;
Barac, Ana;
Stanway, Susanna;
Moslehi, Javid;
Suter, Thomas M.;
Ky, Bonnie;
Štěrba, Martin;
Cardinale, Daniela;
Cohen‐Solal, Alain;
Tocchetti, Carlo Gabriele;
Farmakis, Dimitrios;
Bergler‐Klein, Jutta;
Anker, Markus S.;
Von Haehling, Stephan;
Belenkov, Yury

Publication type:

journal article

Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2160, doi. 10.1002/ejhf.2015

By:

Teerlink, John R.;
Diaz, Rafael;
Felker, G. Michael;
McMurray, John J.V.;
Metra, Marco;
Solomon, Scott D.;
Adams, Kirkwood F.;
Anand, Inder;
Arias‐Mendoza, Alexandra;
Biering‐Sørensen, Tor;
Böhm, Michael;
Bonderman, Diana;
Cleland, John G.F.;
Corbalan, Ramon;
Crespo‐Leiro, Maria G.;
Dahlström, Ulf;
Echeverria Correa, Luis E.;
Fang, James C.;
Filippatos, Gerasimos;
Fonseca, Cândida

Publication type:

Article

Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology).

Published in:

2020

By:

Seferović, Petar M.;
Fragasso, Gabriele;
Petrie, Mark;
Mullens, Wilfried;
Ferrari, Roberto;
Thum, Thomas;
Bauersachs, Johann;
Anker, Stefan D.;
Ray, Robin;
Çavuşoğlu, Yuksel;
Polovina, Marija;
Metra, Marco;
Ambrosio, Giuseppe;
Prasad, Krishna;
Seferović, Jelena;
Jhund, Pardeep S.;
Dattilo, Giuseppe;
Čelutkiene, Jelena;
Piepoli, Massimo;
Moura, Brenda

Publication type:

journal article

Learning together: insights from the first Heart Failure Association patient forum.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1939, doi. 10.1002/ejhf.2013

By:

Jaarsma, Tiny;
Čelutkienė, Jelena;
Lopatin, Yuri;
Vugrač, Luka;
Hill, Loreena;
Strömberg, Anna;
Coats, Andrew J.S.

Publication type:

Article

Ten lessons from the EMPEROR‐Reduced trial.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1991, doi. 10.1002/ejhf.2009

By:

Butler, Javed;
Zannad, Faiez;
Filippatos, Gerasimos;
Anker, Stefan D.;
Packer, Milton

Publication type:

Article

EMPEROR-Reduced: confirming sodium-glucose co-transporter 2 inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction.

Published in:

2020

By:

McMurray, John J.V.

Publication type:

journal article

Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2018, doi. 10.1002/ejhf.2005

By:

Ibrahim, Nasrien E.;
Piña, Ileana L.;
Camacho, Alexander;
Bapat, Devavrat;
Felker, G. Michael;
Maisel, Alan S.;
Butler, Javed;
Prescott, Margaret F.;
Abbas, Cheryl A.;
Solomon, Scott D.;
Januzzi, James L.

Publication type:

Article

Beating the bushes for biomarkers.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2075, doi. 10.1002/ejhf.2004

By:

Richards, A. Mark

Publication type:

Article

Cancer therapy and the heart; the necessity to calibrate risk.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1961, doi. 10.1002/ejhf.1999

By:

Okwuosa, Tochukwu M.;
Keramida, Kalliopi;
Filippatos, Gerasimos;
Yancy, Clyde W.

Publication type:

Article

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2065, doi. 10.1002/ejhf.1988

By:

Piek, Arnold;
Suthahar, Navin;
Voors, Adriaan A.;
Boer, Rudolf A.;
Silljé, Herman H.W.

Publication type:

Article

Serum potassium in the PARADIGM‐HF trial.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2056, doi. 10.1002/ejhf.1987

By:

Ferreira, João Pedro;
Mogensen, Ulrik M.;
Jhund, Pardeep S.;
Desai, Akshay S.;
Rouleau, Jean‐Lucien;
Zile, Michael R.;
Rossignol, Patrick;
Zannad, Faiez;
Packer, Milton;
Solomon, Scott D.;
McMurray, John J.V.

Publication type:

Article

Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2093, doi. 10.1002/ejhf.1984

By:

Selvaraj, Senthil;
Claggett, Brian L.;
Pfeffer, Marc A.;
Desai, Akshay S.;
Mc Causland, Finnian R.;
McGrath, Martina M.;
Anand, Inder S.;
Veldhuisen, Dirk J.;
Kober, Lars;
Janssens, Stefan;
Cleland, John G.F.;
Pieske, Burkert;
Rouleau, Jean L.;
Zile, Michael R.;
Shi, Victor C.;
Lefkowitz, Martin P.;
McMurray, John J.V.;
Solomon, Scott D.

Publication type:

Article

DAPA‐HF: does dapagliflozin provide 'bang for your buck' as a treatment for heart failure with reduced ejection fraction?

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2157, doi. 10.1002/ejhf.1982

By:

Cowie, Martin R.

Publication type:

Article

In search of a 'safety zone' for glycaemic control: association between glycosylated haemoglobin levels and outcomes in patients with type 2 diabetes and cardiovascular disease.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2035, doi. 10.1002/ejhf.1981

By:

Seferović, Petar M.;
Polovina, Marija

Publication type:

Article

Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2147, doi. 10.1002/ejhf.1978

By:

McEwan, Phil;
Darlington, Oliver;
McMurray, John J.V.;
Jhund, Pardeep S.;
Docherty, Kieran F.;
Böhm, Michael;
Petrie, Mark C.;
Bergenheim, Klas;
Qin, Lei

Publication type:

Article

Frailty and the failing heart do not travel alone.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2120, doi. 10.1002/ejhf.1973

By:

Kehler, Dustin S.;
Arora, Rakesh C.

Publication type:

Article

Pathogenesis and management of myocardial injury in coronavirus disease 2019.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1994, doi. 10.1002/ejhf.1967

By:

Wei, Zhi‐Yao;
Geng, Yong‐Jian;
Huang, Ji;
Qian, Hai‐Yan

Publication type:

Article

Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE‐HF cohort study.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2112, doi. 10.1002/ejhf.1926

By:

Matsue, Yuya;
Kamiya, Kentaro;
Saito, Hiroshi;
Saito, Kazuya;
Ogasahara, Yuki;
Maekawa, Emi;
Konishi, Masaaki;
Kitai, Takeshi;
Iwata, Kentaro;
Jujo, Kentaro;
Wada, Hiroshi;
Kasai, Takatoshi;
Nagamatsu, Hirofumi;
Ozawa, Tetsuya;
Izawa, Katsuya;
Yamamoto, Shuhei;
Aizawa, Naoki;
Yonezawa, Ryusuke;
Oka, Kazuhiro;
Momomura, Shin‐ichi

Publication type:

Article

Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2026, doi. 10.1002/ejhf.1958

By:

McAlister, Finlay A.;
Zheng, Yinggan;
Westerhout, Cynthia M.;
Buse, John B.;
Standl, Eberhard;
McGuire, Darren K.;
Van de Werf, Frans;
Green, Jennifer B.;
Armstrong, Paul W.;
Holman, Rury R.

Publication type:

Article

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 1945, doi. 10.1002/ejhf.1920

By:

Lyon, Alexander R.;
Dent, Susan;
Stanway, Susannah;
Earl, Helena;
Brezden‐Masley, Christine;
Cohen‐Solal, Alain;
Tocchetti, Carlo G.;
Moslehi, Javid J.;
Groarke, John D.;
Bergler‐Klein, Jutta;
Khoo, Vincent;
Tan, Li Ling;
Anker, Markus S.;
Haehling, Stephan;
Maack, Christoph;
Pudil, Radek;
Barac, Ana;
Thavendiranathan, Paaladinesh;
Ky, Bonnie;
Neilan, Tomas G.

Publication type:

Article

Assessing frailty in heart failure.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2134, doi. 10.1002/ejhf.1905

By:

Farmakis, Dimitrios;
Thodi, Maria;
Elpidoforou, Michail;
Filippatos, Gerasimos

Publication type:

Article

<sup>18</sup> F-FDG PET/CT brain glucose metabolism as a marker of different types of depression comorbidity in chronic heart failure patients with impaired systolic function.

Published in:

2020

By:

Lyra, Vassiliki;
Parissis, John;
Kallergi, Maria;
Rizos, Emmanouil;
Filippatos, Gerasimos;
Kremastinos, Dimitrios;
Chatziioannou, Sofia

Publication type:

journal article

Depression and heart failure: the lonely comorbidity.

Published in:

2020

By:

Sbolli, Marco;
Fiuzat, Mona;
Cani, Dario;
O'Connor, Christopher M.

Publication type:

journal article

The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE.

Published in:

2020

By:

Dewan, Pooja;
Jackson, Alice;
Jhund, Pardeep S.;
Shen, Li;
Ferreira, João Pedro;
Petrie, Mark C.;
Abraham, William T.;
Desai, Akshay S.;
Dickstein, Kenneth;
Køber, Lars;
Packer, Milton;
Rouleau, Jean L.;
Solomon, Scott D.;
Swedberg, Karl;
Zile, Michael R.;
McMurray, John J.V.

Publication type:

journal article

Age and biomarkers in heart failure: challenging the current model to select patients for clinical trials.

Published in:

2020

By:

Henri, Christine;
Mielniczuk, Lisa;
O'Meara, Eileen

Publication type:

Editorial

Cardiac iron concentration in relation to systemic iron status and disease severity in non-ischaemic heart failure with reduced ejection fraction.

Published in:

2020

By:

Hirsch, Valentin G.;
Tongers, Jörn;
Bode, Julia;
Berliner, Dominik;
Widder, Julian D.;
Escher, Felicitas;
Mutsenko, Vitalii;
Chung, Bomee;
Rostami, Fatemeh;
Guba‐Quint, Anja;
Giannitsis, Evangelos;
Schultheiss, Heinz‐Peter;
Vogt, Carla;
Bauersachs, Johann;
Wollert, Kai C.;
Kempf, Tibor;
Guba-Quint, Anja;
Schultheiss, Heinz-Peter

Publication type:

journal article

Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N‐terminal pro‐B‐type natriuretic peptide and high‐sensitivity troponin T.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2078, doi. 10.1002/ejhf.1701

By:

Aimo, Alberto;
Januzzi, James L.;
Vergaro, Giuseppe;
Richards, A. Mark;
Lam, Carolyn S.P.;
Latini, Roberto;
Anand, Inder S.;
Cohn, Jay N.;
Ueland, Thor;
Gullestad, Lars;
Aukrust, Pål;
Brunner‐La Rocca, Hans‐Peter;
Bayes‐Genis, Antoni;
Lupón, Josep;
Boer, Rudolf A.;
Takeishi, Yasuchika;
Egstrup, Michael;
Gustafsson, Ida;
Gaggin, Hanna K.;
Eggers, Kai M.

Publication type:

Article

The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach.

Published in:

European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2102, doi. 10.1002/ejhf.1674

By:

Hoes, Martijn F.;
Tromp, Jasper;
Ouwerkerk, Wouter;
Bomer, Nils;
Oberdorf‐Maass, Silke U.;
Samani, Nilesh J.;
Ng, Leong L.;
Lang, Chim C.;
Harst, Pim;
Hillege, Hans;
Anker, Stefan D.;
Metra, Marco;
Veldhuisen, Dirk J.;
Voors, Adriaan A.;
Meer, Peter

Publication type:

Article

Issue Information.

Published in:: European Journal of Heart Failure, 2020, v. 22, n. 11, p. i, doi. 10.1002/ejhf.1962
Publication type:: Article

November 2020 at a glance: focus on comorbidities and medical treatment.

Published in:

2020

By:

Tomasoni, Daniela;
Adamo, Marianna;
Metra, Marco

Publication type:

journal article